Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Assets Average (2017 - 2025)

Historic Assets Average for Adma Biologics (ADMA) over the last 14 years, with Q3 2025 value amounting to $563.5 million.

  • Adma Biologics' Assets Average rose 4694.16% to $563.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $563.5 million, marking a year-over-year increase of 4694.16%. This contributed to the annual value of $408.9 million for FY2024, which is 2069.19% up from last year.
  • Latest data reveals that Adma Biologics reported Assets Average of $563.5 million as of Q3 2025, which was up 4694.16% from $534.5 million recorded in Q2 2025.
  • Adma Biologics' Assets Average's 5-year high stood at $563.5 million during Q3 2025, with a 5-year trough of $221.7 million in Q1 2021.
  • For the 5-year period, Adma Biologics' Assets Average averaged around $350.7 million, with its median value being $340.0 million (2024).
  • Per our database at Business Quant, Adma Biologics' Assets Average tumbled by 133.36% in 2024 and then surged by 4698.02% in 2025.
  • Adma Biologics' Assets Average (Quarter) stood at $257.4 million in 2021, then increased by 26.05% to $324.5 million in 2022, then rose by 4.49% to $339.1 million in 2023, then rose by 29.66% to $439.6 million in 2024, then grew by 28.18% to $563.5 million in 2025.
  • Its Assets Average stands at $563.5 million for Q3 2025, versus $534.5 million for Q2 2025 and $499.6 million for Q1 2025.